A seldom mentioned distinction between Baraclude and Tyzeka: The Baraclude FDA label has Pregnancy Category C while the Tyzeka FDA label has Pregnancy Category B. Category B means that the drug is not teratogenic and has shown no adverse effects in developing embryos and fetuses in preclinical studies.